Gavin Painter
Victoria University of Wellington, NZ, New Zealand
- This delegate is presenting an abstract at this event.

Professor Painter obtained his PhD in chemistry from the University of Otago in 1995 (synthetic methodology) which was followed by postdoctoral research at the University of Cambridge (the synthesis of inositol phospholipids for the elucidation of PI3K pathways). Since joining the Ferrier Research Institute in New Zealand his research laboratory has focussed on the synthesis of lipid-based materials including phosphatidyl inositol mannosides, glycolipids, glycolipid-peptide conjugates and novel lipid nano-delivery vehicles for encapsulation of various vaccine components including RNA, peptides, glycolipids and various immune stimulates.
Professor Painter has a strong interest in the immunological evaluation of vaccines and vaccine components. He holds a joint position with the Malaghan Institute of Medical Research Wellington New Zealand incorporating multiple national and international collaborations with immunologists.
Presentations this author is a contributor to:
Synthesis and antitumour activity of 6''-thio-6''-deoxy-α-galactosylceramide (#91)
4:00 PM
Benjamin Compton
Poster Listing
Synthetic glycolipid-peptide conjugate vaccines utilise NKT cell help in vivo for improved CD8+ T cell immune responses (#52)
6:56 PM
Taryn Osmond
Rapid Fire Talks II
An NKT cell-activating glycolipid-peptide conjugate vaccine enhances human anti-viral CD8+ T cell responses (#84)
4:00 PM
Astrid Authier-Hall
Poster Listing
A phase I dose escalation trial of immunisation with autologous dendritic cells pulsed with NY-ESO-1 peptide and α-galactosylceramide in patients with high-risk surgically resected stage II, III or IV melanoma (#100)
4:00 PM
Olivier Gasser
Poster Listing